Have you been observing the rotation to value stocks and wondering if it’s sustainable? If so, you’re invited to watch this call replay where our PMs offer their perspectives on today’s market.
The new year began with the Georgia Senate runoff which saw both seats going to Democrats, thereby giving the Dems an effective majority in the Senate. Unshockingly, a new $1.9 trillion stimulus package was passed along party lines soon thereafter.
First and foremost, we hope this writing finds you and your families healthy. It’s been a long twelve months and no one could be criticized for being happy to see the end of 2020. So much changed so quickly at the beginning of the year, as COVID-19 rapidly spread around the world, creating the first global pandemic of our lifetimes.
Concerned about richly priced growth stocks, a return of inflation and the lack of yield available in the bond market? Our new whitepaper explores how value stocks can provide solutions.
Nervous about market volatility and thinking of ways to mitigate downside risk? Learn more about Prospector’s approach, which focuses on the potential downside first.
The benchmark S&P 500 continued its charge higher during the third quarter, despite significant
increases in COVID-19 cases and certain states such as Florida, Texas, Arizona and California seeing
Interested in why Prospector focuses on the potential downside first? We’d be happy to coordinate a call between you and a portfolio manager.
Insurance is something everyone uses but few people think of as a strong investment opportunity. In this whitepaper we illustrate the key differences and pros/cons of every insurance segment we invest in.
We now know second-quarter GDP contracted over 30%. In retrospect, the sharp rally in equities that took place seems incredible. In our Q2 commentary we look at what has been driving the markets and offer our outlook for the rest of 2020.
These are uncharted waters for all of us. The COVID-19 virus pandemic is first and foremost a health crisis with associated economic and financial fallout. The health data relative to testing is spotty and poor.